Authorization No. 131501-9B
February 26, 2015
Pursuant to Workers' Compensation Law Section 13-d(4), the Chair of the New York State Workers' Compensation Board has exercised his authority to temporarily suspend Dr. Monica Mehta’s authorization to treat injured workers within the New York State workers’ compensation system effective February 6, 2015. Dr. Mehta's last known business address is 8 Glenview Drive, Warren, New Jersey 07059.
The Chair’s designee’s investigation revealed that the New York State Department of Health, State Board for Professional Medical Conduct (BPMC) issued Order #14-269, wherein Dr. Mehta was subjected to a Censure and Reprimand, a license condition prohibiting the practice of medicine in the State of New York without prior approval from the Director of the Office of Professional Medical Conduct, and a $3,000.00 fine. This was the result of the New Jersey Board of Medical Examiners’ finding that Dr. Mehta knowingly prepared written statements containing false or misleading material information and submitted those documents to an insurance company on three separate occasions, resulting in a one-year stayed suspension and probationary term and a $10,000.00 fine. Investigation has also shown that Dr. Mehta sent to the Board correspondence on at least two occasions stating her intentions to bill the claimant directly or send the claimant’s medical bills to collection proceedings in connection with medical care rendered for a work injury, in violation of Workers’ Compensation Law § 13-f(1).
Therefore, the Chair believes that Dr. Mehta may be guilty of misconduct, and that such misconduct would detrimentally affect the quality of care provided to injured workers.
Dr. Mehta is prohibited from rendering treatment and care to injured workers while her authorization is temporarily suspended. Reports submitted by Dr. Mehta for services rendered prior to February 6, 2015, are valid, but are invalid for any services rendered on or after that date. Requests to cross-examine Dr. Mehta for services rendered prior to February 6, 2015, should not be denied due to the suspension of her authorization.
This suspension remains in effect until further notice. Any questions regarding the authorized lists should be referred to the Medical Director’s Office at 1 (800) 781-2362.
Robert E. Beloten